Univariate analysis, chi-square | Multivariate analysis | ||||
---|---|---|---|---|---|
Variable | Serious complications, number (%) | Non serious complications number (%) | P Value | Hazard ratio (95% CI) | P value |
Number | 74 (2.3) | 3,092 (97.6) | |||
Resident niveau, yes | 19 (25.3) | 1353 (434) | 0.002 | 0.069 | |
Oxygen, yes | 9 (12) | 136 (4.4) | 0.006 | 2.58 (1.21; 5.13) | 0.013 |
Acute indication, yes | 58 (77.3) | 2,016 (64.6) | 0.027 | 0.78 | |
Age >60 years, yes | 16 (21.3) | 554 (17.8) | 0.25 | 0.32 | |
Age <25 years, yes | 9 (12) | 211 (6.8) | 0.09 | 0.09 | |
Time >20 min, yes | 30 (40) | 956 (30.6) | 0.09 | 0.27 | |
Bronchiolitis obliterans syndrome, yes | 36 (48) | 1,191 (38.2) | 0.09 | 0.15 | |
Balloon, yes | 14 (18.9) | 106 (3.4) | <0.001 | 5.8 (3.0; 11.5) | < 0.001 |
TBB, yes | 3 (4.1) | 718 (23.2) | <0.001 | 5.85 (1.827; 18.770) | 0.003 |
BAL, yes | 51 (68.9) | 2,551 (82.2) | 0.006 | 0.8 | |
Argon therapy, yes | 18 (24.3) | 452 (14.6) | 0.03 | 0.44 | |
Sedation, yes | 23 (30.7) | 436 (14) | <0.001 | 2.12 (1.2; 3.6) | 0.005 |
Mitomycin. yes | 2 (2.7) | 126 (4.1) | 0.76 | 4.82 (1.064; 21.853) | 0.041 |
Anti-tussive, yes | 0 | 10 (0.3) | 1 |